Ascend Wellness Holdings (AAWH) Restructuring Costs (2021 - 2022)
Ascend Wellness Holdings (AAWH) posted quarterly Restructuring Costs of $5.0 million for Q1 2022, down 86.31% year-over-year from $36.5 million in Q1 2021, and down 86.31% quarter-over-quarter from $36.5 million in Q1 2021.
Ascend Wellness Holdings (AAWH) Restructuring Costs (2021 - 2022) Analysis & Trends
Ascend Wellness Holdings' Restructuring Costs history runs 2 years deep, the most recent figure standing at $5.0 million for Q1 2022.
- In Q1 2022, Restructuring Costs fell 86.31% year-over-year to $5.0 million; the TTM figure through Dec 2022 stood at $5.0 million (down 86.31% YoY), while the FY2025 annual figure was $17.0 million, changed N/A from the prior year.
- Restructuring Costs for Q1 2022 stood at $5.0 million, down from $36.5 million in the prior quarter.
- The five-year high for Restructuring Costs was $36.5 million in Q1 2021, with the low at $5.0 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 5.00 Mn |
| Mar 31, 2021 | 36.51 Mn |